Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

4.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.4K
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

2.9K
The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunity Gone Viral: Subacute Cognitive Decline With Multifocal Brain Lesions in Neuromyelitis Optica Spectrum Disorder.

Neurology(R) neuroimmunology & neuroinflammation·2026
Same author

Fluorescein-Guided Surgery for Medial Plantar Nerve Intraneural Ganglion Cysts: 2-Dimensional Operative Video.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Nearest-neighbors assisted unsupervised analysis for methylation array profiling for central nervous system tumors.

Brain pathology (Zurich, Switzerland)·2026
Same author

The Evolving Role of Clinical Anatomy: From Definition to Contribution.

Clinical anatomy (New York, N.Y.)·2026
Same author

The Future of AI and Radiology Is Not as Simple as You Think.

Radiology·2026
Same author

Temporal evolution of tumefactive neurolymphomatosis with serial MRI and positron emission tomography: illustrative case.

Journal of neurosurgery. Case lessons·2026

Related Experiment Video

Updated: Aug 23, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K

Malignant Melanotic Nerve Sheath Tumor.

J C Benson1, M D Marais2, P M Flanigan3

  • 1From the Department of Radiology (J.C.B., M.D.M.) benson.john3@mayo.edu.

AJNR. American Journal of Neuroradiology
|October 27, 2022
PubMed
Summary

Malignant melanotic nerve sheath tumors are rare, aggressive spinal nerve tumors. Early identification and distinct management are vital due to overlapping imaging features with benign tumors.

More Related Videos

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

18.7K

Related Experiment Videos

Last Updated: Aug 23, 2025

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.1K
Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

18.7K

Area of Science:

  • Oncology
  • Radiology
  • Pathology

Background:

  • Malignant melanotic nerve sheath tumors (MMNSTs) are rare, pigmented Schwann cell-origin tumors.
  • They constitute less than 1% of all nerve sheath tumors and often occur along spinal nerves.
  • Physicians may be unfamiliar with MMNSTs due to their rarity and overlapping imaging features with benign schwannomas and neurofibromas.

Purpose of the Study:

  • To review the imaging appearance, histologic features, and management of MMNSTs.
  • To highlight the importance of identifying MMNSTs due to their aggressive nature.
  • To discuss surgical resection and therapeutic strategies for lumbar MMNSTs.

Main Methods:

  • Radiology-pathology review.
  • Case study of a patient with a lumbar MMNST.
  • Discussion of imaging findings, histologic characteristics, surgical techniques, and treatment options.

Main Results:

  • MMNSTs present imaging features that can overlap with benign nerve sheath tumors.
  • These tumors are aggressive and require management distinct from benign counterparts.
  • Optimal treatment involves surgical resection and tailored therapeutic strategies.

Conclusions:

  • Accurate identification of MMNSTs is critical for appropriate patient management.
  • The aggressive behavior of MMNSTs necessitates prompt and specialized therapeutic interventions.
  • This review provides insights into the diagnosis and treatment of these uncommon tumors.